A Bioequivalence Study of Dexlansoprazole From Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 mg Delayed Release (DR) Capsules (Takeda Pharmaceuticals America Inc., USA)
Condition: HealthyInterventions: Drug: Doxirazole; Drug: DexilantSponsors: Genuine Research Center, Egypt; Hikma Pharma,EgyptCompleted - verified August 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 19, 2015 Category: Research Source Type: clinical trials
